SLC6A3 and drug-induced dyskinesia: SLC6A3 SNPs have shown associations with dyskinesia (Kaiser et al., 2003; Kaplan et al., 2014), VHs (Schumacher-Schuh et al., 2013), and motor response to acute levodopa challenge (Moreau et al., 2015).